Singapore Clinical Trial: An open-label, roll-over study evaluating the long-term safety and efficacy of an oral dose of verducatib q.d. in patients with bronchiectasis (AIRTIVITY®-ON)

Singapore, Oct. 16 -- The Health Sciences Authority received information related to the study titled 'An open-label, roll-over study evaluating the long-term safety and efficacy of an oral dose of verducatib q.d. in patients with bronchiectasis (AIRTIVITY®-ON)'. The following are the other relevant details related to the trial:

Therapeutic Area: Respiratory

Trial Centre(s): Changi General Hospital National University Hospital Singapore General Hospital Tan Tock Seng Hospital

Trial Status: NA

Principal Investigator(s): Dr Isaac Fong Jun Jie Dr Liew Mei Fong Dr Mariko Koh Siyue Dr Lim Yick Hou Albert

Published by HT Digital Content Services with permission from Health Daily Digest....